Sangamo Therapeutics, Inc (SGMOQ): Weighted Average Diluted Shares
280.19M
Year ended 2025-12-31
+22.0%
3-year compound annual growth
+15.8%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 280.19M | +38.9% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | 201.70M | +15.6% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | 174.44M | +13.0% | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | 154.34M | +6.8% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | 144.57M | +7.5% | 2024-03-13, From 2021-01-01 |
| 2020-12-31 | 134.45M | +19.9% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | 112.11M | n/a | 2022-02-24, From 2019-01-01 |